Surfacide

Surfacide Introducing our FDA Approved Helios+ UV-C System for Whole Room Microbial Reduction.

Surfacide is a leading UV-C technology and infection prevention company creating cleaner, safer environments through scientifically proven, hospital-grade solutions.

08/11/2026

The countdown to AHE Exchange26 is on!

In just five days, the Surfacide team will be in New Orleans for the Association for the Health Care Environment (AHE) Exchange26, connecting with EVS professionals and healthcare leaders from across the country.

If you’re attending, make Surfacide's Booth #246 one of your stops — and be sure to add this General Session to your schedule:

UV Devices in the Healthcare Environment: Considerations EVS Professionals Should Know

Tuesday, August 18 | 8:00–9:30 a.m. CST

The session will bring together leaders from the FDA, infection prevention, and environmental services to explore important considerations around UV technology, including regulatory oversight, validation, safety, and implementation in healthcare environments.

We’re looking forward to the conversation and to seeing you at Exchange26.

Stop by Booth #246 to meet our team and learn more about our FDA-authorized Helios+ UV technology.

Confidence starts with confidence in your process.When environmental services teams have the right tools, they gain more...
08/06/2026

Confidence starts with confidence in your process.

When environmental services teams have the right tools, they gain more than another step in the cleaning process. They gain greater confidence in the outcomes.

Here’s what one EVS Director from a 2,000+ bed acute care facility shared about their experience with Surfacide:

“The biggest difference for our team has been the added confidence in our infection prevention process and our ability to provide a safer environment for patients. Surfacide has enhanced our terminal cleaning practices by giving us an additional layer of disinfection for high-risk rooms and isolation discharges. It has also strengthened our partnership with Infection Prevention, improved our UV completion rates, and provided valuable data that helps us track utilization, drive accountability, and support patient safety initiatives.”

When teams are supported with technology that reinforces their workflow, the impact goes far beyond cleaning.

If you’re attending AHE Exchange26 in New Orleans later this month, one session we’re especially looking forward to is:U...
08/03/2026

If you’re attending AHE Exchange26 in New Orleans later this month, one session we’re especially looking forward to is:

UV Devices in the Healthcare Environment: Considerations EVS Professionals Should Know

Tuesday, August 18 | 8:00–9:30 a.m. (CST)

As UV technology continues to become an important part of healthcare environmental hygiene, conversations around device evaluation, regulatory oversight, validation, safety, and implementation have never been more relevant. This General Session brings together respected leaders from the FDA, infection prevention, and environmental services to discuss the evolving role of UV technology and what EVS professionals should know.

We’ll be there listening, learning, and continuing the conversation throughout the conference.

Stop by Booth 246 to meet the Surfacide team and learn more about our FDA-authorized Helios+ technology.





We’re heading to New Orleans for AHE Exchange26!Join us August 16–19 at Booth 246.Meet our team and discover how the FDA...
07/27/2026

We’re heading to New Orleans for AHE Exchange26!

Join us August 16–19 at Booth 246.

Meet our team and discover how the FDA-authorized Helios+ UVC System for Whole Room Microbial Reduction, featuring patented three-emitter technology, helps environmental services teams deliver simple, efficient room treatment without repositioning emitters.

We look forward to seeing you in New Orleans!

Manual cleaning is essential—but it’s only one part of a comprehensive infection prevention strategy.Even the most thoro...
07/17/2026

Manual cleaning is essential—but it’s only one part of a comprehensive infection prevention strategy.

Even the most thorough cleaning protocols have limitations. That’s why many healthcare facilities add UV-C technology as an additional layer to help reduce microorganisms throughout the patient environment.

By combining manual cleaning with UV-C technology, hospitals can strengthen their environmental hygiene protocols and support safer care for patients and staff.

See how Helios+ helps healthcare facilities go beyond manual cleaning: https://bit.ly/HeliosPlus-FB

As we celebrate Independence Day and 250 years of American history, we reflect on the values that continue to unite us -...
07/02/2026

As we celebrate Independence Day and 250 years of American history, we reflect on the values that continue to unite us - innovation, resilience, service, and the pursuit of a better future.

We’re grateful for the healthcare professionals, veterans, first responders, and essential workers who dedicate themselves every day to protecting the health and well-being of our communities.

From all of us at Surfacide, we wish you a safe, happy, and meaningful Fourth of July.

Happy Independence Day!

In healthcare, regulation isn’t a barrier. It’s a safeguard.Not all oversight is the same.When UV-C systems are used in ...
06/30/2026

In healthcare, regulation isn’t a barrier. It’s a safeguard.

Not all oversight is the same.

When UV-C systems are used in patient care environments, healthcare facilities deserve confidence that the technology has been independently evaluated for the things that matter most.

FDA authorization includes evaluations beyond EPA oversight, including:

• Electrical safety
• Electromagnetic compatibility (EMC)
• Cybersecurity
• Validated performance in healthcare settings

These are critical considerations when technology is deployed around patients, staff, and clinical workflows.

As hospitals continue to raise the bar for infection prevention, independent evaluation helps provide confidence that performance and safety claims have been rigorously assessed.

At Surfacide, we believe healthcare deserves that higher standard.

While we appreciate the communication from APIC to attendees on the trade show floor regarding Whole Room Microbial Redu...
06/15/2026

While we appreciate the communication from APIC to attendees on the trade show floor regarding Whole Room Microbial Reduction Devices, this category has been clearly defined by the FDA since 2023.

It is increasingly concerning to see manufacturers exhibit and market at national infection prevention conferences in the US trying to sidestep this regulatory requirement, whether by citing EPA registration or suggesting their devices avoid medical device surfaces.

In practice, non-critical medical device surfaces encompass the entire patient environment, including bedrails, IV poles, tray tables, nurse call buttons, sinks, toilets, door handles, workstations, and more. There is no alternative pathway for these claims in healthcare settings.

Find us at booth 1617 and learn more about the FDA’s QXJ category.

 

Live from APIC 2026.You’ll see a lot of UV technology on the show floor this week. But only two exhibitors at APIC 2026 ...
06/15/2026

Live from APIC 2026.

You’ll see a lot of UV technology on the show floor this week. But only two exhibitors at APIC 2026 are currently FDA authorized for Whole Room Microbial Reduction under the FDA’s QXJ classification.

Today, Surfacide and Xenex are jointly reinforcing an important message for healthcare leaders:

FDA Authorization for Whole Room Microbial Reduction is NOT OPTIONAL for UV used in the presence of non-critical medical device surfaces.

Stop by our booths to learn more about:

FDA’s Whole Room Microbial Reduction category

Why authorization matters

What Infection Preventionists should know when evaluating UV technologies

Surfacide and Xenex may compete in the marketplace, but we share a commitment to ensuring the healthcare community is not left with the impression that FDA authorization for UV technologies used in healthcare environments is optional, unnecessary, or interchangeable with EPA oversight for this intended use.

Find us at APIC: Surfacide Booth 1617 Xenex Booth 2203

 

We may compete in the marketplace. But on one issue, we agree:FDA Authorization for Whole Room Microbial Reduction is NO...
06/11/2026

We may compete in the marketplace. But on one issue, we agree:

FDA Authorization for Whole Room Microbial Reduction is NOT OPTIONAL for UV used in the presence of non-critical medical device surfaces.

At APIC 2026, Surfacide and Xenex are proud to support greater awareness of the FDA’s QXJ Whole Room Microbial Reduction device classification and what it means for healthcare organizations focused on patient safety, compliance, and evidence-based technology decisions.

All UV technologies marketed for microbial reduction in healthcare settings where non-critical medical device surfaces are present are required to have FDA authorization. Yet at the nation’s largest conference for Infection Preventionists, currently only two exhibitors have achieved this.

Find us at APIC:
Surfacide Booth 1617 Xenex Booth 2203

Address

W226 N918 Northmound Drive Suite 300
Waukesha, WI
53186

Website

Alerts

Be the first to know and let us send you an email when Surfacide posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Establishment

Send a message to Surfacide:

Shortcuts

Share